Monimus Capital Management, LP Roivant Sciences Ltd. Transaction History
Monimus Capital Management, LP
- $106 Billion
- Q4 2024
A detailed history of Monimus Capital Management, LP transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Monimus Capital Management, LP holds 137,058 shares of ROIV stock, worth $1.59 Million. This represents 1.53% of its overall portfolio holdings.
Number of Shares
137,058Holding current value
$1.59 Million% of portfolio
1.53%Shares
1 transactions
Others Institutions Holding ROIV
# of Institutions
321Shares Held
505MCall Options Held
573KPut Options Held
739K-
Qvt Financial LP New York, NY65.8MShares$761 Million76.3% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X062.1MShares$718 Million6.45% of portfolio
-
Viking Global Investors LP47.8MShares$553 Million1.91% of portfolio
-
Vanguard Group Inc Valley Forge, PA40.8MShares$472 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$409 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $8.15B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...